BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8359829)

  • 1. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
    Kalia VK
    Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
    Kalia VK; Devi NK
    Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK; Prabhakara S; Narayanan V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Varshney R; Dwarakanath B; Jain V
    Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose.
    Kalia VK
    Indian J Med Res; 1999 May; 109():182-7. PubMed ID: 10643143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of radiation damage in transformed mammalian cells by 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose.
    Kalia VK; Jain V
    Indian J Exp Biol; 1993 Mar; 31(3):224-30. PubMed ID: 8500838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
    Khaitan D; Chandna S; Dwarakanath SB
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
    Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose on the radiosensitivity of proliferating transformed mammalian cells.
    Kalia VK; Jain V
    Indian J Exp Biol; 1991 Sep; 29(9):826-30. PubMed ID: 1794865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro.
    Swamy RK; Manickam J; Adhikari JS; Dwarakanath BS
    Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in radiation induced cell cycle perturbations by 2-deoxy-D-glucose in human tumor cell lines.
    Adhikari JS; Dwarakanath BS; Mathur R; Ravindranath T
    Indian J Exp Biol; 2003 Dec; 41(12):1392-9. PubMed ID: 15320491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gamma-rays and glucose analogs on the energy metabolism of a cell line derived from human cerebral glioma.
    Dwarakanath BS; Jain V
    Indian J Biochem Biophys; 1991 Jun; 28(3):203-9. PubMed ID: 1786971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line.
    Varshney R; Adhikari JS; Dwarakanath BS
    Indian J Exp Biol; 2003 Dec; 41(12):1384-91. PubMed ID: 15320490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro radiation responses of human intracranial meningiomas & their modifications by 2-deoxy-D-glucose.
    Dwarakanath BS; Jain V
    Indian J Med Res; 1990 Jun; 92():183-8. PubMed ID: 2401539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
    Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.
    Dwarakanath BS; Singh D; Banerji AK; Sarin R; Venkataramana NK; Jalali R; Vishwanath PN; Mohanti BK; Tripathi RP; Kalia VK; Jain V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S21-6. PubMed ID: 20009289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the radiation induced damage by 2-deoxy-D-glucose in organ cultures of human cerebral gliomas.
    Dwarakanath BS; Jain VK
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):741-6. PubMed ID: 3570897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.